LUNA Trademark

Trademark Overview

On Wednesday, January 19, 2022, a trademark application was filed for LUNA with the United States Patent and Trademark Office. The USPTO has given the LUNA trademark a serial number of 97227100. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Wednesday, May 21, 2025. This trademark is owned by Adverum Biotechnologies, Inc.. The LUNA trademark is filed in the Pharmaceutical Products category with the following description:

Ocular pharmaceuticals; Pharmaceutical preparations for the treatment of vascular endothelial growth factor (VEGF)-mediated ocular diseases

General Information

Serial Number97227100
Word MarkLUNA
Filing DateWednesday, January 19, 2022
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateWednesday, May 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesOcular pharmaceuticals; Pharmaceutical preparations for the treatment of vascular endothelial growth factor (VEGF)-mediated ocular diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAdverum Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events

Event DateEvent Description
Saturday, January 22, 2022NEW APPLICATION ENTERED
Tuesday, January 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 27, 2022ASSIGNED TO EXAMINER
Thursday, October 27, 2022NON-FINAL ACTION WRITTEN
Thursday, October 27, 2022NON-FINAL ACTION E-MAILED
Thursday, October 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, March 19, 2023LETTER OF SUSPENSION E-MAILED
Sunday, March 19, 2023SUSPENSION LETTER WRITTEN
Sunday, March 19, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 28, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, March 29, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, October 4, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, April 12, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, May 21, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, May 22, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 22, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 22, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, April 12, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

luna ocular factor vegf mediated diseases growth vascular pharmaceuticals pharmaceutical preparations